Nov 29, 2022 08:00AM
Nov 29, 2022 08:00AM
Nov 18, 2022 08:00AM
Nov 18, 2022 08:00AM
Nov 11, 2022 12:04PM
Nov 11, 2022 12:00PM
Nov 11, 2022 12:00PM Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting with Data on CAN-2409 in Combination with Nivolumab in a Phase 1 Mechanistic Clinical Trial in Patients with High-G
Sep 6, 2022 08:00AM
Sep 6, 2022 08:00AM
May 26, 2022 05:31PM
May 26, 2022 05:30PM
May 26, 2022 05:30PM
May 18, 2022 08:00AM
May 18, 2022 08:00AM Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
Apr 27, 2022 04:00PM
Apr 27, 2022 04:00PM
Mar 2, 2022 08:00AM
Mar 2, 2022 08:00AM
Mar 2, 2022 08:00AM
Mar 1, 2022 08:07AM
Mar 1, 2022 08:00AM Candel Therapeutics Announces $25 Million Non-dilutive Debt Financing Agreement with Silicon Valley Bank
Mar 1, 2022 08:00AM
Feb 3, 2022 08:02AM
Feb 3, 2022 08:00AM
Feb 3, 2022 08:00AM
Jan 5, 2022 08:00AM
Jan 5, 2022 08:00AM
Nov 2, 2021 08:00AM Candel Therapeutics to Participate in Three Upcoming Investor Conferences
Nov 2, 2021 08:00AM
Nov 1, 2021 08:00AM
Nov 1, 2021 08:00AM
Oct 28, 2021 08:01AM
Oct 28, 2021 08:00AM
Oct 28, 2021 08:00AM
Oct 19, 2021 08:00AM Candel Therapeutics Appoints Mace L. Rothenberg, MD, as Senior Advisor to the Chief Executive Officer
Oct 19, 2021 08:00AM
Oct 4, 2021 08:00AM
Oct 4, 2021 08:00AM
Oct 1, 2021 08:00AM
Oct 1, 2021 08:00AM
Sep 9, 2021 08:00AM
Sep 9, 2021 08:00AM Candel Therapeutics Announces Presentations of Key Clinical Data at AdMeTech and European Association of Neuro-Oncology Conferences in September 2021
Sep 8, 2021 08:00AM
Sep 8, 2021 08:00AM
Sep 7, 2021 08:00AM
Sep 7, 2021 08:00AM
Jul 26, 2021 06:46AM

66,415 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All